Topical Wharton's Jelly MSC-Derived Age Zero™ Exosome Treatments After Micro-Needling for Skin Rejuvenation
- PMID: 39367640
- PMCID: PMC11626297
- DOI: 10.1111/jocd.16561
Topical Wharton's Jelly MSC-Derived Age Zero™ Exosome Treatments After Micro-Needling for Skin Rejuvenation
Conflict of interest statement
Dr. Corine Cicchetti is the Chief Medical Officer of Regenerelle and Resiliélle has consultative or financial relationships with several of study the investigators may have with the BRMA and affiliates.
Figures

References
-
- Bang C. and Thum T., “Exosomes: New Players in Cell‐Cell Communication,” International Journal of Biochemistry & Cell Biology 44, no. 11 (2012): 2060–2064. - PubMed
-
- Taghavi‐Farahabadi M., Mahmoudi M., Rezaei N., and Hashemi S. M., “Wharton's Jelly Mesenchymal Stem Cells Exosomes and Conditioned Media Increased Neutrophil Lifespan and Phagocytosis Capacity,” Immunological Investigations 50, no. 8 (2021): 1042–1057. - PubMed
LinkOut - more resources
Full Text Sources